CL2017000125A1 - New crystalline form of 5-chloro-n - ({(5s) -2-oxo-3- [4- (5,6-dihydro-4h- [1,2,4] triazin-1-yl) phenyl methanesulfonate ] -1,3-oxazolidin-5-yl} methyl) thiophene-2-carboxamide and pharmaceutical composition containing the same. - Google Patents

New crystalline form of 5-chloro-n - ({(5s) -2-oxo-3- [4- (5,6-dihydro-4h- [1,2,4] triazin-1-yl) phenyl methanesulfonate ] -1,3-oxazolidin-5-yl} methyl) thiophene-2-carboxamide and pharmaceutical composition containing the same.

Info

Publication number
CL2017000125A1
CL2017000125A1 CL2017000125A CL2017000125A CL2017000125A1 CL 2017000125 A1 CL2017000125 A1 CL 2017000125A1 CL 2017000125 A CL2017000125 A CL 2017000125A CL 2017000125 A CL2017000125 A CL 2017000125A CL 2017000125 A1 CL2017000125 A1 CL 2017000125A1
Authority
CL
Chile
Prior art keywords
oxazolidin
triazin
carboxamide
oxo
methyl
Prior art date
Application number
CL2017000125A
Other languages
Spanish (es)
Inventor
Soongyu Choi
Jungsub Choi
So-Hyun Yoon
Yoo Hoon Kim
Jae Yeon Kim
Suk Ho Lee
Young Lag Cho
Ho Young Song
Dae Yon Lee
Sung Yoon Baek
Sang Eun Chae
Tae Kyo Park
Sung Ho Woo
Yong Zu Kim
Original Assignee
Green Cross Corp
Legochem Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60331246&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2017000125(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Green Cross Corp, Legochem Biosciences Inc filed Critical Green Cross Corp
Priority to CL2017000125A priority Critical patent/CL2017000125A1/en
Publication of CL2017000125A1 publication Critical patent/CL2017000125A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<p>LA PRESENTE INVENCIÓN SE REFIERE A UNA NUEVA FORMA CRISTALINA DE METANOSULFONATO DE 5-CLORO-N-({(5S)-2-OXO-3-[4-(5,6-DIHIDRO-4H-[1,2,4]TRIAZIN-1-IL)FENIL]-1,3-OXAZOLIDIN-5-IL}METIL)TIOFENO-2-CARBOXAMIDA Y A UNA COMPOSICIÓN FARMACÉUTICA QUE CONTIENE LA MISMA. LA NUEVA FORMA CRISTALINA DE UN COMPUESTO DE ACUERDO CON LA PRESENTE INVENCIÓN, PRESENTA EXCELENTE ESTABILIDAD INCLUSO A ALTA TEMPERATURA Y EN AMBIENTES HÚMEDOS Y, POR LO TANTO, PUEDE SER USADA DE MANERA FAVORABLE PARA PREVENIR O TRATAR ENFERMEDADES, TALES COMO TROMBOSIS, INFARTO AL MIOCARDIO, ARTERIOESCLEROSIS, INFLAMACIÓN, DERRAME CEREBRAL, ANGINA DE PECHO, ESTENOSIS DESPUÉS DE ANGIOPLASTIA, Y TROMBOEMBOLISMO.</p><p> THIS INVENTION REFERS TO A NEW CRYSTAL METHODOSULFONATE FORM OF 5-CHLORINE-N - ({(5S) -2-OXO-3- [4- (5,6-DIHIDRO-4H- [1,2 , 4] TRIAZIN-1-IL) PHENYL] -1,3-OXAZOLIDIN-5-IL} METHYL) THIOPHEN-2-CARBOXAMIDE ALREADY A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME. THE NEW CRYSTAL FORM OF A COMPOUND IN ACCORDANCE WITH THE PRESENT INVENTION, PRESENTS EXCELLENT STABILITY INCLUDING HIGH TEMPERATURE AND IN HUMID ENVIRONMENTS AND, THEREFORE, MAY BE USED FAVORABLELY TO PREVENT OR TREAT DISEASES, AS ISSUANCE, AS BOTH , ARTERIOESCLEROSIS, INFLAMMATION, BRAIN SPILL, ANGINA OF CHEST, ESTENOSIS AFTER ANGIOPLASTIA, AND THROMBOEMBOLISM. </p>

CL2017000125A 2017-01-17 2017-01-17 New crystalline form of 5-chloro-n - ({(5s) -2-oxo-3- [4- (5,6-dihydro-4h- [1,2,4] triazin-1-yl) phenyl methanesulfonate ] -1,3-oxazolidin-5-yl} methyl) thiophene-2-carboxamide and pharmaceutical composition containing the same. CL2017000125A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2017000125A CL2017000125A1 (en) 2017-01-17 2017-01-17 New crystalline form of 5-chloro-n - ({(5s) -2-oxo-3- [4- (5,6-dihydro-4h- [1,2,4] triazin-1-yl) phenyl methanesulfonate ] -1,3-oxazolidin-5-yl} methyl) thiophene-2-carboxamide and pharmaceutical composition containing the same.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2017000125A CL2017000125A1 (en) 2017-01-17 2017-01-17 New crystalline form of 5-chloro-n - ({(5s) -2-oxo-3- [4- (5,6-dihydro-4h- [1,2,4] triazin-1-yl) phenyl methanesulfonate ] -1,3-oxazolidin-5-yl} methyl) thiophene-2-carboxamide and pharmaceutical composition containing the same.

Publications (1)

Publication Number Publication Date
CL2017000125A1 true CL2017000125A1 (en) 2017-08-18

Family

ID=60331246

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017000125A CL2017000125A1 (en) 2017-01-17 2017-01-17 New crystalline form of 5-chloro-n - ({(5s) -2-oxo-3- [4- (5,6-dihydro-4h- [1,2,4] triazin-1-yl) phenyl methanesulfonate ] -1,3-oxazolidin-5-yl} methyl) thiophene-2-carboxamide and pharmaceutical composition containing the same.

Country Status (1)

Country Link
CL (1) CL2017000125A1 (en)

Similar Documents

Publication Publication Date Title
BR112015007937A2 (en) crystalline forms of a factor xia inhibitor
CU20170077A7 (en) COMPOSITE DERIVED FROM BENZAMIDE REPLACED WITH 1,3-TIAZOL-2-ILO USEFUL FOR THE TREATMENT OF NEUROGENIC DISORDERS, COMPOSITIONS AND COMBINATIONS THAT UNDERSTAND IT
AR109300A2 (en) CRYSTALLINE FORMS OF ACID 3- [5- (2-FLUOROPHENIL) - [1,2,4] OXADIAZOL-3-IL] -BENZOICO
GEAP202015005A (en) Diacylglycerol acyltransferase 2 inhibitors
DOP2006000209A (en) SOLID PHARMACEUTICAL PRESENTATION FORM OF ORAL ADMINISTRATION WITH FAST RELEASE OF THE ACTIVE PRINCIPLE
CO6501189A2 (en) DERIVATIVES OF OXAZINE AND ITS USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
EA201592146A1 (en) HETEROAROMATIC COMPOUNDS AND THEIR APPLICATION AS LIGANDS TO DOPAMINE D1-RECEPTORS
EA201792421A1 (en) AMIDO-SUBSTITUTED DERIVATIVES OF CYCLOGEXANE
EA201500953A1 (en) 3-ACETYLAMINO-1- (PENILHETEROARYLAMINOCARBONYL OR PHENILGETEROARILCARBONYLAMINO) BENZENE DERIVATIVES FOR THE TREATMENT OF HYPER-PROLIFERATIVE DISABILITIES
AR111469A1 (en) COME OUT OF AN AMINOPIRIDINE DERIVATIVE COMPOUND, A CRYSTAL FORM OF THE SAME, AND A PROCESS TO PREPARE THE SAME
EA201691881A1 (en) NEW CONNECTIONS
CL2015000002A1 (en) Pharmaceutical administration form comprising 5-chloro-n - ({(5s) -2-oxo -3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide; procedure of preparation and use in the prophylaxis and / or treatment of thromboembolic disorders.
MX2018014298A (en) NEW CRYSTAL FORM OF N- [5- (3,5-DIFLUORO-BENCILO) -1H-INDAZOL-3 -IL] -4- (4-METHYL-PIPERAZINA-1-IL) -2- (TETRAHIDRO-PIRANO-4 -ILAMINO) -BENZAMIDA.
WO2014147182A3 (en) Substituted n-biphenyl-3-acetylamino-benzamides and n-[3-(acetylamino)phenyl]-biphenyl-carboxamides and their use as inhibitors of the wnt signalling pathway
ATE440839T1 (en) AMINOACYL PRODRUG DERIVATIVES AND MEDICINAL PRODUCTS FOR THE TREATMENT OF THROMBOEMBOLIC DISEASES
BR112016024825A2 (en) rivaroxaban-containing composition and process for making a composition comprising rivaroxaban
WO2012080184A3 (en) Liquid pharmaceutical compositions which can be administered orally and contain 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophene carboxamide
MX2017000409A (en) Novel crystalline form of 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihyd ro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thi ophene-2-carboxamide methanesulfonate and pharmaceutical composition containing same.
IN2012MU03359A (en)
BR112017023639A2 (en) PROCESS FOR THE PREPARATION OF AN ANTICANCERIGENE AGENT, 1 - ((4- (4-FLUORO-2-METHYL-1H-INDOL-5-ILOXI) -6-METOXI-QUINOLIN-7-ILOXI) METHYL) CYCLOPROPANAMINE, ITS CRYSTALLINE FORM AND ITS SALTS
PL397924A1 (en) Medical use of the substance of 5-(3-chlorophenyl)-4-(4-fluorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
CU23673B7 (en) ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE